Hemgenix Drug Interactions: What to Avoid and What to Tell Your Doctor

Hemgenix (etranacogene dezaparvovec-drlb) does not have extensive listed drug-drug interactions in the traditional pharmacological sense — it is a gene therapy, not a small-molecule drug. However, its unique mechanism of action in the liver means that certain substances, medications, and even lifestyle choices can significantly affect its safety profile and effectiveness. Understanding these interactions is essential for everyone receiving Hemgenix.

Hepatotoxic Agents: The Most Important Interaction Category

The most clinically significant interaction concern for Hemgenix is any agent that is toxic to the liver (hepatotoxic). Because Hemgenix works by transducing liver cells with the F9 gene, the health of those liver cells directly impacts Factor IX production. If liver cells are damaged by hepatotoxic agents — particularly in the first year after infusion, when liver enzyme monitoring is most intensive — it can:

Worsen any immune-mediated hepatotoxicity from the gene therapy itself

Damage the transduced hepatocytes that are producing Factor IX, potentially reducing or eliminating efficacy

Lead to more serious hepatic reactions requiring more aggressive treatment

Alcohol

Alcohol is a significant hepatotoxin, particularly with regular or heavy use. The European Medicines Agency's prescribing information for Hemgenix specifically warns that physicians should factor in alcohol consumption when evaluating a patient's suitability for Hemgenix and when managing hepatic reactions post-infusion. Patients are strongly advised to avoid alcohol — especially in the first year after infusion when the transduced liver cells are most vulnerable.

Herbal Supplements and Natural Products

Many herbal supplements and natural products have hepatotoxic potential that is often underrecognized. The Hemgenix prescribing information specifically warns about potentially hepatotoxic herbal products and nutritional supplements. Examples to discuss with your doctor include:

Kava (Piper methysticum): Well-documented liver toxicity; avoid entirely.

Comfrey: Contains pyrrolizidine alkaloids associated with liver damage; avoid.

High-dose green tea extract: Concentrated green tea supplements (not regular tea) have been associated with liver toxicity.

Pennyroyal oil, chaparral, and certain Chinese herbal formulations: Known hepatotoxins; avoid.

Always disclose all supplements, herbs, and vitamins to your doctor before and after Hemgenix infusion.

Corticosteroids (Used Therapeutically After Hemgenix)

Corticosteroids (primarily oral prednisolone or prednisone) are actively prescribed as a therapeutic intervention after Hemgenix if liver enzyme elevations occur. This is an intentional use, not an adverse interaction — corticosteroids suppress the immune-mediated hepatotoxicity response.

However, an indirect interaction exists: drugs that affect the CYP3A4 enzyme pathway can alter the plasma concentration of corticosteroids, affecting how well they work. Specifically:

CYP3A4 inducers (such as rifampin, phenytoin, carbamazepine, and St. John's Wort) can reduce corticosteroid levels, potentially making them less effective at treating liver enzyme elevations.

CYP3A4 inhibitors (such as certain antifungals like ketoconazole, certain HIV medications, and grapefruit juice) can increase corticosteroid levels, amplifying their side effects.

Disclose all medications you're taking to your treating hematologist before Hemgenix infusion, so they can plan for corticosteroid management if needed.

Exogenous Factor IX Concentrates

Using exogenous (externally administered) Factor IX concentrates before and after Hemgenix infusion can interfere with laboratory assessment of Factor IX activity levels derived from Hemgenix itself. If you receive Factor IX infusions after Hemgenix, your lab results may not accurately reflect how much Factor IX your body is producing from the gene therapy. Your hematologist should use the same assay and reagents consistently over time to minimize this confounding effect.

Strenuous Exercise

Vigorous physical activity can cause transient ALT and AST elevations through muscle-related mechanisms. This is not a drug interaction in the traditional sense, but it can confound post-Hemgenix liver monitoring. Before your weekly blood draws in the first 3 months post-infusion, avoid strenuous exercise for at least 48 hours to ensure your liver enzyme readings accurately reflect the post-Hemgenix hepatic response rather than exercise-related muscle enzyme release.

What to Tell Your Doctor Before Hemgenix

Before Hemgenix infusion, give your hematologist a complete list of:

All prescription medications (including any CYP3A4 inducers or inhibitors)

Over-the-counter medications (including acetaminophen at high doses, NSAIDs)

All supplements, vitamins, and herbal products

Alcohol consumption habits

Any history of hepatitis B or C, liver disease, or alcohol-related liver injury

For more on side effects and monitoring, see Hemgenix Side Effects: What to Expect. If you're still working to access Hemgenix, visit medfinder.com to find treatment centers near you with available supply.